Gå direkt till huvudinnehållet

Toxiskt chocksyndrom

Senast uppdaterad: Publicerad:


  1. Cosgrove SE, Zaleznik DF. Staphylococcal toxic shock syndrome. UpToDate, March 31, 2004. UpToDate  
  2. Todd J, Fishaut M, Kapral F, Welch T. Toxic-shock syndrome associated with phage-group-I Staphylococci. Lancet 1978; 2: 1116. PubMed  
  3. Davis JP, Chesney PJ, Want PJ, et al. Toxic-shock syndrome. N Engl J Med 1980; 303: 1429. New England Journal of Medicine  
  4. Hajjeh RA, Reingold A, Weil A, et al. Toxic shock syndrome in the United States: surveillance update, 1979-1996. Emerg Infect Dis 1999; 5: 807. PubMed  
  5. Reingold AL, Hargrett NT, Shands KN, et al. Toxic shock syndrome surveillance in the United States, 1980 to 1981. Ann Intern Med 1982; 96: 875. Annals of Internal Medicine  
  6. Osterholm MT, Davis JP, Gibson RW, et al. Toxic shock syndrome: relation to catamenial products, personal health and hygiene, and sexual practices. Ann Intern Med 1982; 96: 954. Annals of Internal Medicine  
  7. Broome CV. Epidemiology of toxic shock syndrome in the United States: overview. Rev Infect Dis 1989; 11 Suppl 1: S14.
  8. Gaventa S, Reingold AL, Hightower, AW, et al. Active surveillance for toxic shock syndrome in the United States, 1986. Rev Infect Dis 1989; 11 Suppl 1:S28.
  9. Morrison VA, Oldfield EC 3rd. Postoperative toxic shock syndrome. Arch Surg 1983; 118: 791. PubMed  
  10. Lehn, N, Schaller, E, Wagner, H, Kronke, M. Frequency of toxic shock syndrome toxin- and enterotoxin-producing clinical isolates of Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 1995; 14: 43. PubMed  
  11. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997; 10: 505. PubMed  
  12. Schlievert PM. Role of superantigens in human disease. J Infect Dis 1993; 167: 997. PubMed  
  13. Vergeront, JM, Stolz, SJ, Crass, BA, et al. Prevalence of serum antibody to staphylococcal enterotoxin F among Wisconsin residents: implications for toxic-shock syndrome. J Infect Dis 1983; 148: 692. PubMed  
  14. Bonventre, PF, Linnemann, C, Weckbach, LS, et al. Antibody responses to toxic-shock-syndrome (TSS) toxin by patients with TSS and by healthy staphylococcal carriers. J Infect Dis 1984; 150: 662. PubMed  
  15. Bohach, GA, Fast, DJ, Nelson, RD, Schlievert, PM. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol 1990; 17: 251. PubMed  
  16. Tofte, RW, Williams, DN. Toxic shock syndrome. Evidence of a broad clinical spectrum. JAMA 1981; 246: 2163. Journal of the American Medical Association  
  17. Bartlett, P, Reingold, AL, Graham, DR, et al. Toxic shock syndrome associated with surgical wound infections. JAMA 1982; 247: 1448. Journal of the American Medical Association  
  18. Chesney, PJ. Clinical aspects and spectrum of illness of toxic shock syndrome: overview. Rev Infect Dis 1989; 11 Suppl 1: S1.
  19. Chesney, PJ, Davis, JP, Purdy, WK, et al. Clinical manifestations of toxic shock syndrome. JAMA 1981; 246: 741. Journal of the American Medical Association  
  20. Chesney, RW, Chesney, PJ, Davis, JP, Segar, WE. Renal manifestations of the staphylococcal toxic-shock syndrome. Am J Med 1981; 71: 583. PubMed  
  21. Barrett, JA, Graham, DR. Toxic shock syndrome presenting as encephalopathy. J Infect 1986; 12: 276. PubMed  
  22. Rosene, KA, Copass, MK, Kastner, LS, et al. Persistent neuropsychological sequelae of toxic shock syndrome. Ann Intern Med 1982; 96: 865. Annals of Internal Medicine  
  23. Davis, JP, Osterholm, MT, Helms, CM, et al. Tri-state toxic-shock syndrome study. II. Clinical and laboratory findings. J Infect Dis 1982; 145: 441. PubMed  
  24. Reingold, AL, Dan, BB, Shands, KN, Broome, CV. Toxic-shock syndrome not associated with menstruation. A review of 54 cases. Lancet 1982; 1: 1. PubMed  
  25. Schlievert, PM, Kelly, JA. Clindamycin-induced suppression of toxic-shock syndrome--associated exotoxin production. J Infect Dis 1984; 149: 471. PubMed  
  26. Todd, JK, Ressman, M, Caston, SA, et al. Corticosteroid therapy for patients with toxic shock syndrome. JAMA 1984; 252: 3399. Journal of the American Medical Association  
  27. Davis, JP, Osterholm, MT, Helms, CM, et al. Tri-state toxic-shock syndrome study. II. Clinical and laboratory findings. J Infect Dis 1982; 145: 441. PubMed  
  28. Sharma S, Harding G, Dolynchuk K. Toxic Shock Syndrome. eMedicine Specialties. Updated: Oct 5, 2006. emedicine.medscape.com  
  • Bertil Christensson, professor och överläkare, Infektionskliniken, Skånes universitetssjukhus

Tidigare sakkunniga

  • Per Bergsjø, professor, specialist i förlossningshjälp och kvinnosjukdomar, Universitetet i Bergen
  • Ingard Løge, specialist inom allmänmedicin, Institutt for samfunnsmedisinske fag, Norges teknisk-naturvitenskapelige universitet, Trondheim